Natural Product: NPC88557

Natural Product IDNPC88557
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Schisantherin A
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL565966
PubChem CID 45484556
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VJGNXZQPNWMFAQ-SSEZWIOCSA-N
Standard InCHI InChI=1S/C29H30O9/c1-15-11-17-12-20-24(37-14-36-20)23(30)21(17)22-18(13-19(33-3)25(34-4)26(22)35-5)27(29(15,2)32)38-28(31)16-9-7-6-8-10-16/h6-10,12-13,15,27,30,32H,11,14H2,1-5H3/t15-,27-,29-/m0/s1
SMILES COc1cc2c(c(c1OC)OC)c1c(cc3c(c1O)OCO3)C[C@@H]([C@]([C@H]2OC(=O)c1ccccc1)(C)O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   522.19 Volume:   520.105
?
Van der Waals volume.
Dense:   1.004 LogP:   3.982
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.378
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.51
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   29.0
TPSA:   112.91
?
Topological Polar Surface Area.
H-Bond Acceptor:   9.0
H-Bond Donor:   2.0 Rings:   5.0
Heavy Atoms:   9.0

MedChem Properties

QED Drug-Likeness Score:   0.462 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.905 Fsp3:   0.345
MCE-18:   104.205
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.444 Fluc inhibitor:   0.104
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.436
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.74
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.052 Promiscuous compounds:   0.158

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.115 MDCK Permeability:   -4.789
Pgp-inhibitor:   0.01 Pgp-substrate:   0.007
PAMPA:   0.751
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.045 30% Bioavailability (F30%):   0.001
50% Bioavailability (F50%):   0.815

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.066 MRP1:   1.0
Plasma Protein Binding (PPB):   96.546% Volume Distribution (VD):   0.017
Fu: 2.971%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.974
OATP1B3 inhibitor:   0.981 BCRP inhibitor:   0.018
BSEP inhibitor:   0.996

ADMET: Metabolism

CYP1A2-inhibitor:   0.373 CYP1A2-substrate:   0.947
CYP2C19-inhibitor:   0.994 CYP2C19-substrate:   0.424
CYP2C9-inhibitor:   0.406 CYP2C9-substrate:   0.013
CYP2D6-inhibitor:   0.008 CYP2D6-substrate:   0.779
CYP3A4-inhibitor:   0.999 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.979
HLM stability:   0.598
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.779 Half-life (T1/2):  1.164

ADMET: Toxicity

hERG Blockers:  0.208 hERG Blockers (10um):  0.741
Human Hepatotoxicity (H-HT):  0.294 Drug-induced Liver Injury (DILI):  0.908
AMES Toxicity:  0.424 Rat Oral Acute Toxicity:  0.319
Maximum Recommended Daily Dose:  0.761 Skin Sensitization:  0.917
Carcinogencity:  0.946 Eye Corrosion:  0.0
Eye Irritation:  0.429 Respiratory Toxicity:  0.628
Drug-induced Neurotoxicity:  0.848 Ototoxicity:  0.347
Hematotoxicity:  0.16 Drug-induced Nephrotoxicity:  0.848
Genotoxicity:  0.567 RPMI-8226 Immunitoxicity:  0.279
A549 Cytotoxicity:  0.716 Hek293 Cytotoxicity:  0.839
BCF:   1.333
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.101
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.641
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.901
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33401 schisandra sphenathera Species Schisandraceae Eukaryota stems n.a. n.a. PMID[23237974]
NPO8367 Fructus schiandrae n.a. n.a. n.a. n.a. n.a. n.a. Database[COCONUT]
NPO25239 Kadsura peltigera Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8367 Fructus schiandrae n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO25239 Kadsura peltigera Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO25239 Kadsura peltigera Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8367 Fructus schiandrae n.a. n.a. n.a. n.a. n.a. n.a. Database[TCMID]
NPO25239 Kadsura peltigera Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO25239 Kadsura peltigera Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1594 Individual protein Multidrug resistance-associated protein 1 Homo sapiens IC50 = 0.0004 ug.mL-1 PMID[17129588]
NPT1594 Individual protein Multidrug resistance-associated protein 1 Homo sapiens IC50 = 1.597 ug.mL-1 PMID[17129588]
NPT1594 Individual protein Multidrug resistance-associated protein 1 Homo sapiens IC50 = 0.0033 ug.mL-1 PMID[17129588]
NPT1594 Individual protein Multidrug resistance-associated protein 1 Homo sapiens IC50 = 0.058 ug.mL-1 PMID[17129588]
NPT1594 Individual protein Multidrug resistance-associated protein 1 Homo sapiens IC50 = 0.085 ug.mL-1 PMID[17129588]
NPT1594 Individual protein Multidrug resistance-associated protein 1 Homo sapiens IC50 = 0.855 ug.mL-1 PMID[17129588]
NPT67 Individual protein Cholinesterase Equus caballus Inhibition = -0.32 % PMID[23062825]
NPT4026 Individual protein DNA-binding protein inhibitor ID-1 Homo sapiens Inhibition = 41.0 % PMID[23237974]
NPT66 Individual protein Acetylcholinesterase Electrophorus electricus Inhibition = 5.31 % PMID[23062825]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT659 Cell line SMMC-7721 Homo sapiens IC50 > 100000.0 nM PMID[23237974]
NPT165 Cell line HeLa Homo sapiens IC50 = 74300.0 nM PMID[23237974]
NPT71 Cell line HEK293 Homo sapiens Inhibition = 10.9 % PMID[24018191]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 > 100000.0 nM PMID[23237974]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 100000.0 nM PMID[23237974]
NPT963 Organism Hepatitis B virus Hepatitis B virus Inhibition = 23.9 % PMID[19640714]
NPT963 Organism Hepatitis B virus Hepatitis B virus Inhibition = 0.0 % PMID[19640714]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference
- Artemia salina LC50 = 73.5 ug.mL-1 PMID[23237974]

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC88557 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7703 Intermediate Similarity NPC83049
0.7703 Intermediate Similarity NPC320471
0.7703 Intermediate Similarity NPC118162
0.7432 Intermediate Similarity NPC79322
0.7105 Intermediate Similarity NPC42797
0.7089 Intermediate Similarity NPC485504
0.679 Remote Similarity NPC311912
0.5714 Remote Similarity NPC291977
0.557 Remote Similarity NPC252286
0.5541 Remote Similarity NPC184684
0.5541 Remote Similarity NPC184641
0.5529 Remote Similarity NPC483405
0.5309 Remote Similarity NPC121661
0.5301 Remote Similarity NPC473445
0.5294 Remote Similarity NPC475756
0.5294 Remote Similarity NPC280778
0.5244 Remote Similarity NPC191352
0.5238 Remote Similarity NPC126405
0.5238 Remote Similarity NPC53669
0.5238 Remote Similarity NPC77237
0.5238 Remote Similarity NPC297271
0.5238 Remote Similarity NPC224472
0.5238 Remote Similarity NPC16791
0.5238 Remote Similarity NPC217708
0.5172 Remote Similarity NPC474606
0.5114 Remote Similarity NPC29727
0.5109 Remote Similarity NPC230531
0.5062 Remote Similarity NPC73467
0.5059 Remote Similarity NPC258322

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC88557 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data